Metraipolis › archive › dc_fde8efb13432

Coverage with evidence development for medicines with insufficient evidence of clinical benefit: experience from the Netherlands — Europe PMC PMID:41243444

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41243444
DOI
10.1017/s0266462325103267
License (as archived)
solo-consultazione
Archived
2026-11-08T12:01:51.905Z
SHA-256 of the archived text
a7447327a0ad2fcf4e081a2accc0b649513fa9ed8ddcf760021a1e84689a57bf
Stable URL of this page
https://metraipolis.com/documento/dc_fde8efb13432

How to cite

Coverage with evidence development for medicines with insufficient evidence of clinical benefit: experience from the Netherlands — Europe PMC PMID:41243444 — Europe PMC (en), https://europepmc.org/article/MED/41243444 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fde8efb13432 (Metraipolis archive dc_fde8efb13432, sha256 a7447327a0ad2fcf4e081a2accc0b649513fa9ed8ddcf760021a1e84689a57bf)
BibTeX
@misc{dcfde8efb13432,
  title = {Coverage with evidence development for medicines with insufficient evidence of clinical benefit: experience from the Netherlands — Europe PMC PMID:41243444},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41243444},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fde8efb13432; sha256 a7447327a0ad2fcf4e081a2accc0b649513fa9ed8ddcf760021a1e84689a57bf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41243444. Agents can read the archived copy with the MCP tool read_document.